StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$26.90−0.55 (-2.00%)

Close on Nov 18, 2026Market cap $1.30BP/E –Yield –

Nanobiotix revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was €32.59M. The highest annual figure on record is €36.21M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€32.59M–
FY2024Dec 31, 2024-€7.19M-119.9%
FY2023Dec 31, 2023€36.21M+658.1%
FY2022Dec 31, 2022€4.78M+80.4%
FY2021Dec 31, 2021€2.65M+5.4%
FY2020Dec 31, 2020€2.51M-1.1%
FY2019Dec 31, 2019€2.54M-27.0%
FY2018Dec 31, 2018€3.48M–

More Nanobiotix figures

See a number that looks wrong?